"Peripheral Arterial Disease Market Poised to Witness High Growth Due to Rising Cases of Cardiovascular Diseases"



Peripheral arterial disease (PAD) is a circulatory problem in which narrowed arteries reduce blood flow to limbs, usually the legs. Common symptoms of PAD include pain in hips, thighs or calves when walking that goes away with rest. This occurs because of the build-up of plaque in the arteries that supply blood to the legs. There is a significant need for treatments of PAD as it can increase the risk of heart attack or stroke. The global peripheral arterial disease market consists of drugs that help improve symptoms, reduce plaques and open blocked arteries. These include antiplatelet drugs, statins, angioplasty balloons and stents.

The global peripheral arterial disease market is estimated to be valued at US$ 4.8 Bn in 2024 and is expected to exhibit a CAGR of 6.8% over the forecast period 2024-2031.

Key Takeaways
Key players operating in the peripheral arterial disease market include Novartis, Bayer, Pfizer, Amgen and Sanofi. These companies offer a range of drugs and devices to treat PAD.
There are significant opportunities in the Asia Pacific region due to the growing elderly population suffering from PAD and increasing healthcare expenditures. Europe currently dominates the global market owing to rising cases of diabetes and high acceptance of advanced treatment options.
North America is witnessing high demand for drugs and devices to enhance blood circulation in limbs. Major players are focusing on business expansion strategies across Middle East and Latin America.

Market Drivers
Rising prevalence of cardiovascular diseases such as atherosclerosis, diabetes and obesity is a major factor driving the growth of the peripheral arterial disease market. According to WHO, over 75% deaths due to PAD occur in low and middle-income countries.
Growing geriatric population is also contributing to the market growth as risk of PAD increases with age. Players are investing heavily in R&D to develop novel drugs with fewer side effects.

Market Restrains
High costs associated with surgical procedures and lack of awareness about symptoms in developing nations are some of the factors hindering the market growth. Strong regulations for approval of drugs and medical devices also poses a challenge for market players.

Segment Analysis
The peripheral arterial disease market is segmented based on treatment type, disease type, and end user. By treatment type, the peripheral arterial disease market is segmented into medications and revascularization. The revascularization segment is dominating the market due to rise in preference for minimally invasive procedures. The key procedures performed under revascularization include angioplasty, stenting, and atherectomy. By disease type, the market is segmented into intermittent claudication and critical limb ischemia. Critical limb ischemia is the dominating sub segment as it requires immediate medical intervention and has higher risk of amputation if left untreated. By end user, the market is segmented into hospitals, clinics, and ambulatory surgical centers. Hospitals dominating the end user segment due to availability of advanced treatment facilities and skilled surgeons.

Global Analysis
Regionally, North America is the dominating as well as the fastest growing regional market for peripheral arterial disease. Factors such as rise in prevalence of cardiovascular diseases, developed healthcare infrastructure, and favorable reimbursement policies are driving the growth of the North America peripheral arterial disease market. Europe holds the second largest market share owing to increasing adoption of minimally invasive procedures. However, Asia Pacific region is expected to witness highest growth during the forecast period majorly due to rising healthcare spending, availability of generic drugs, and growing medical tourism in the region.

Get more insights on this topic : https://justpaste.it/gt8xn

What Are The Key Data Covered In This Peripheral Arterial Disease  Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Peripheral Arterial Disease 's growth between 2024 and 2031.

:- Accurate calculation of the size of the Peripheral Arterial Disease  and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- Peripheral Arterial Disease  Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Peripheral Arterial Disease  vendors

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it

Comments

Post a Comment

Popular posts from this blog

Laser Projection Market is to Witness High Growth Owing to Advancements in RGB Laser Projection Technology

Image
  The laser projection market involves the usage of laser diodes and phosphor wheels to project images instead of traditional light bulbs and rotating color wheels. Laser projection technology offers a variety of benefits over conventional projection including high brightness levels, long lifespan, high resolutions, and high contrast ratios. Laser projectors are increasingly being used for entertainment and commercial applications such as cinemas, digital signage, and conferences & seminars. The demand for   Laser Projection Market is driven by the superior image quality, higher resolutions and brighter images they provide compared to conventional projectors. The laser projection market is estimated to be valued at   USD 17.52 Bn in 2024   and is expected to reach   USD 56.28 Bn by 2031,  growing at a compound annual growth rate  (CAGR) of 18.1% from 2024 to 2031.  Key Takeaways Key players: Key players operating in the laser projection...
Read more

AL Amyloidosis Diagnostics is to Witness High Growth due to Advancements in Molecular Diagnostics and Flow Cytometry

Image
AL amyloidosis, also called primary (AL) amyloidosis, is a plasma cell disorder characterized by the buildup of abnormal protein deposits known as amyloid in tissues and organs. AL amyloidosis can affect the heart, kidneys, liver, nervous system, and digestive system. Early and precise diagnosis of AL Amyloidosis Diagnostics Market is very important for effective treatment and management of the disease. The AL amyloidosis diagnostic market is estimated to be valued at  USD 1.068 billion in 2024   and is expected to reach   USD 1.693 billion by 2031 , growing at a compound annual growth rate   (CAGR) of 6.8% from 2024 to 2031. Key Takeaways Key players operating in the AL amyloidosis diagnostics are Siemens Healthineers, Abbott Laboratories, IMMUNOConcepts, PrognostiX, Ark Diagnostics. The key opportunities in the AL amyloidosis diagnostics market include development of minimally invasive diagnostic techniques, adoption of PET imaging for diagnosis, advanceme...
Read more

Navigating the Stuttering Treatment Market: Top Solutions for Effective Speech Therapy

Image
The stuttering treatment market involves speech therapy techniques that help reduce or eliminate stuttering or stammering symptoms. Stuttering or stammering occurs when the flow of speech is disrupted by involuntary blocking, repetition, or prolongation of certain sounds. Such involuntary disruptions create difficulties in expressing thoughts fluently which can negatively impact an individual's self-confidence and social interactions. The need for effective Stuttering Market treatment solutions is rising due to the availability of advanced methods such as modified fluency shaping techniques, delayed auditory feedback devices, and self-therapy programs. The Global Stuttering Market is estimated to be valued at   USD 51.5 million in 2024   and is expected to reach   USD 150.1 million by 2031 , growing at a compound annual growth rate   (CAGR) of 11.3% from 2024 to 2031. Key Takeaways Key players operating in the stuttering treatment market are Johnson & Johns...
Read more